CD34 and neoplasm: Postoperative pathology revealed multiple GISTs of high risk (NIH 2008 Revised GIST Hazard Grading System), and tumor cells were positive for CD117, DOG-1, and SMA; partially positive for CD34; and the Ki-67 index was 2%.